Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with diabetic peripheral neuropathy 2. Participants willing and able to participate in this study for entire trial period with informed consent. 3. Participants fit for basti, shalishastikapindaswedana and sarvangaswedana
Exclusion criteria
Exclusion criteria: 1. Patient, suffering from any acute or chronic debilitating disease (conditions involving cardiac, vascular, hematological, respiratory, hepatic, gastrointestinal, renal functions,central nervous system. or psychiatric disorder or active cancer). 2. Type 1 Diabetes Mellitus or Uncontrolled diabetes mellitus 3. Patients with long term steroid treatment. 4. Participants Not fit for Basti, ShaliShastikaPindaswedana and SarvangaSwedana
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in timed up and go test TUG pre and post treatmentTimepoint: outcome will be assessed at baseline and 2 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Toronto Clinical Neuropathy Score pre & post treatment Changes in the Diabetic Neuropathy Symptom score pre & post treatment Changes in Biochemical parameters FBS PPBS LFT & RFT pre & post treatmentTimepoint: outcome will be assessed at Baseline & 2 week | — |
Countries
India
Contacts
National Institute Of ayurveda